Influvax Tetra0.5 ml/pre-filled syringe
Rx- Generic:
- Inactivated Influenza Vaccine
- Company:
- Incepta Pharmaceuticals Ltd.
- Dosage form:
- IM Injection
- Pack size:
- 0.5 ml pre-filled syringe
৳ 950/unit
Description
Influvax Tetra 0.5 ml/pre-filled syringe is a im injection manufactured by Incepta Pharmaceuticals Ltd. in Bangladesh. Its active ingredient is Inactivated Influenza Vaccine.
Indications
Prophylaxis of influenza (flu), especially in those who run an increased risk of associated complications. The use of Influvax Tetra should be based on official recommendations.
Contraindications
Hypersensitivity to the active substances, to any of the excipients and to residues, e.g. eggs, chicken proteins, such as ovalbumin. The vaccine may contain residues of the following substances, e.g. kanamycin and neomycin sulphate, formaldehyde, cetyltrimethylammonium bromide (CTAB) and polysorbate 80. Immunisation shall be postponed in patients with febrile illness or acute infection.
Composition
One dose (0.5 ml) contains Influenza virus surface antigens (haemagglutinin and neuraminidase), propagated in fertilized hen’s eggs from healthy chicken flocks, and inactivated with formaldehyde, of the following strains:
A/California/07/2009 (H1N1)-like strain (A/California/07/2009, NYMC X-181): 15 micrograms. haemagglutinin
A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009, NYMC X-187): 15 micrograms haemagglutinin.
B/Brisbane/60/2008-like strain (B/Brisbane/60/2008): 15 micrograms haemagglutinin.
Dosage & Administration
- Dosage
- Adults and children over 36 months of age: 0.5ml
- Children from 6 to 35 months of age: clinical data are limited. Doses of 0.25 ml or 0.5 ml have been used.
- Administrations
- : For children who have not previously been vaccinated, a second dose should be given after an interval of at least 4 weeks. If half a dose (0.25 ml) is to be administered, discard half the contained volume (up to the mark indicated on the syringe barrel), before injection. Immunisation should be carried out by intramuscular or deep subcutaneous injection. The vaccine should be allowed to reach room temperature before use. Shake before use. Seroprotection is generally obtained within 2 to 3 weeks. The duration of postvaccinal immunity to homologous strains or to strains closely related to the vaccine strains varies but is usually 6-12 months.
Interaction
Influvax Tetra may be given at the same time as other vaccines. Immunisation should be carried out on separate limbs. It should be noted that the adverse reactions may be intensified. The immunological response may be diminished if the patient is undergoing immunosuppressant treatment. Following influenza vaccination, false positive results in serology tests using the ELISA method (blood test) to detect antibodies against HIV1, Hepatitis C and especially HTLV1 have been observed. The Western Blot technique disproves the false-positive ELISA results. The transient false positive reactions could be due to the IgM response by the vaccine.
Pregnancy & Lactation
The limited data from vaccinations in pregnant women do not indicate that adverse foetal and maternal outcomes were attributable to the vaccine. The use of this vaccine may be considered from the second trimester of pregnancy. For pregnant women with medical conditions that increase their risk of complications from influenza, administration of the vaccine is recommended, irrespective of their stage of pregnancy. Inactivated Influenza Vaccine may be used during lactation.
Precautions & Warnings
Antibody response in patients with endogenous (due to illness) or iatrogenic (due to medicine) immunosuppression (poor immune response) may be insufficient. As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine. Influvax Tetra should under no circumstances be administered intravascularly.
Therapeutic Class
Vaccines, Anti-sera & Immunoglobulin
Storage Conditions
Influvax Tetra must be stored in a refrigerator (2°C-8°C). Do not freeze. Keep the syringe in the outer carton in order to protect from light. Any unused product or waste material should be disposed of in accordance with local requirements.
Disclaimer: This information is for reference only. Always consult a registered physician before taking any medicine.
Price comparison
- This brand
- ৳ 950
This is the cheapest brand of this generic
Compared against 1 brands
At a glance
Inactivated Influenza Vaccine is used for prophylaxis of influenza (flu), especially in those with increased risk of associated complications.
Indications
- Prophylaxis of influenza (flu) - especially in those with increased risk of complications
Dosage
Adults and children over 36 months:
- 0.5 ml (single dose)
Children (6-35 months):
- Limited clinical data; 0.25 ml or 0.5 ml doses have been used
- If not previously vaccinated, second dose after at least 4 weeks
Administration: Intramuscular or deep subcutaneous injection; allow to reach room temperature before use; shake before use
Side effects
Common Side Effects:
- Pain and redness at injection site
- Fever after vaccination
Precautions & warnings
Precautions:
- Allow to reach room temperature before use
- Shake before use
- Antibody response may be insufficient in patients with endogenous or iatrogenic immunosuppression
- Medical supervision should be available for rare anaphylactic events
- Never administer intravascularly
- Postpone vaccination in febrile illness or acute infection